| Theme | Therapeutic drugs for osteoporosis | |
|---|---|---|
| Title | Antiresorption therapies except bisphosphonates -- SERM, anti–RANKL antibody, vitamin D | |
| Publish Date | 2015/04 | |
| Author | Michiyo Sugiyama | Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| Author | Eriko Kawashima | Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| Author | Kenichirou Morishige | Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| [ Summary ] | Conventionally, bisphosphonates have been administered to elderly patients and patients at high risk. However, various novel anti-resorption drugs have shown wide usefulness with effects seen in both comparatively young patients with osteopenia and in elderly patients at high fracture risk. Therefore, a thorough understanding of the characteristics of each drug along with individualized treatment planning is required. | |